Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Nathalie Costedoat-Chalumeau »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nathalie Corvaia < Nathalie Costedoat-Chalumeau < Nathalie Desuremain  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000165 (2018) Simona Rednic [Roumanie] ; Laura Damian [Roumanie] ; Rosaria Talarico [Italie] ; Carlo Alberto Scirè [Italie] ; Alexander Tobias [Allemagne] ; Nathalie Costedoat-Chalumeau [France] ; David Launay [France] ; Alexis Mathian [France] ; Lisa Matthews [Royaume-Uni] ; Cristina Ponte [Portugal] ; Paola Toniati [Italie] ; Stefano Bombardieri [Italie] ; Charissa Frank [Belgique] ; Matthias Schneider [Allemagne] ; Vanessa Smith [Belgique] ; Maurizio Cutolo [Italie] ; Marta Mosca [Italie] ; Laurent Arnaud [France]Relapsing polychondritis: state of the art on clinical practice guidelines
000195 (2018) Guillaume Moulis [France] ; Grégory Pugnet [France] ; Nathalie Costedoat-Chalumeau [France] ; Alexis Mathian [France] ; Gaëlle Leroux [France] ; Jonathan Boutémy [France] ; Olivier Espitia [France] ; Laurence Bouillet [France] ; Sabine Berthier [France] ; Jean-Baptiste Gaultier [France] ; Pierre-Yves Jeandel [France] ; Amadou Konaté [France] ; Arsène Mékinian [France] ; Elisabeth Solau-Gervais [France] ; Benjamin Terrier [France] ; Daniel Wendling [France] ; Fanny Andry [France] ; Camille Garnier [France] ; Pascal Cathébras [France] ; Laurent Arnaud [France] ; Aurore Palmaro [France] ; Patrice Cacoub [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Philippe Arlet [France] ; Maryse Lapeyre-Mestre [France] ; Laurent Sailler [France]Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.
000286 (2017) Arsene Mekinian [France] ; Guillaume Dervin [France] ; Nathanael Lapidus [France] ; Jean-Emmanuel Kahn [France] ; Louis Terriou [France] ; Eric Liozon [France] ; Eric Grignano [France] ; Jean-Charles Piette [France] ; Odile Beyne Rauzy [France] ; Vincent Grobost [France] ; Pascal Godmer [France] ; Jerome Gillard [France] ; Julien Rossignol [France] ; David Launay [France] ; Achille Aouba [France] ; Thierry Cardon [France] ; Laurence Bouillet [France] ; Jonathan Broner [France] ; Julien Vinit [France] ; Lionel Ades [France] ; Fabrice Carrat [France] ; Clementine Salvado [France] ; Eric Toussirot [France] ; Mathilde Versini [France] ; Nathalie Costedoat-Chalumeau [France] ; Jean Baptiste Fraison [France] ; Philippe Guilpain [France] ; Pierre Fenaux [France] ; Olivier Fain [France]Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients.
000308 (2016) Carina Götestam Skorpen [Norvège] ; Maria Hoeltzenbein [Allemagne] ; Angela Tincani [Italie] ; Rebecca Fischer-Betz [Allemagne] ; Elisabeth Elefant [France] ; Christina Chambers [États-Unis] ; Josè Da Silva [Portugal] ; Catherine Nelson-Piercy [Royaume-Uni] ; Irene Cetin [Italie] ; Nathalie Costedoat-Chalumeau [France] ; Radboud Dolhain [Pays-Bas] ; Frauke Förger [Suisse] ; Munther Khamashta [Royaume-Uni] ; Guillermo Ruiz-Irastorza [Espagne] ; Angela Zink [Allemagne] ; Jiri Vencovsky [République tchèque] ; Maurizio Cutolo [Italie] ; Nele Caeyers [Belgique] ; Claudia Zumbühl [Suisse] ; Monika Stensen [Norvège]The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Biological Products (therapeutic use)
3Female
3Humans
2Aged
2Antirheumatic Agents (therapeutic use)
2Biological Products (adverse effects)
2Drug Therapy, Combination
2Male
2Middle Aged
2Polychondritis, Relapsing (drug therapy)
2Retrospective Studies
2Treatment Outcome
1Abnormalities, Drug-Induced (prevention & control)
1Adult
1Antibodies, Monoclonal, Humanized (pharmacology)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Antirheumatic Agents (adverse effects)
1Antirheumatic Agents (pharmacology)
1Arthritis
1Arthritis, Rheumatoid (drug therapy)
1Arthritis, Rheumatoid (mortality)
1Biological Products (pharmacology)
1Biologics
1Corticosteroids
1Delphi Technique
1Disease-Free Survival
1Drug Administration Schedule
1France
1Glucocorticoids (administration & dosage)
1Immunologic Factors (therapeutic use)
1Infant, Newborn
1Lactation
1Maternal-Fetal Exchange
1Myelodysplastic Syndromes (drug therapy)
1Myelodysplastic Syndromes (mortality)
1Myelodysplastic syndrome
1Polychondritis, Relapsing (mortality)
1Preconception Care (methods)
1Pregnancy
1Pregnancy Complications (drug therapy)
1Pregnancy Outcome
1Prenatal Exposure Delayed Effects
1Relapsing polychondritis
1Remission Induction (methods)
1Rheumatic Diseases (drug therapy)
1Rituximab (pharmacology)
1Rituximab (therapeutic use)
1Tumor Necrosis Factor-alpha (antagonists & inhibitors)
1Vasculitis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Nathalie Costedoat-Chalumeau" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Nathalie Costedoat-Chalumeau" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Nathalie Costedoat-Chalumeau
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021